The company's R&D and production team has more than 20 years of experience in research and development and industrialization in biochemical extraction products, multi-component biochemicals, and synthetic peptide products. We also have the international frontier level of scientific research and industrial transformation especially in the R&D and industrialization of animal protein peptides and nucleic acid drugs and health products. The main products include a variety of high-standard biochemical drugs and APIs. Among them, new drugs named hepatocyte growth-promoting factors enteric-coated capsules, which are independently developed and exclusively produced in the country, have been jointly awarded key new product certificate by the four national ministries and commissions like the State Ministry of Science and Technology, the Ministry of Commerce, and also won a number of Zhejiang and Hangzhou Science and Technology Progress Awards. On July 19, 2018, the group became a drug marketing license holder for hepatocyte growth-promoting enteric-coated capsules and transfer factor capsules.

     Zhejiang Huadi Pharmaceutical Group is a drafting unit of the GMP appendix of the national pharmaceutical production quality management standard. The main scientific researchers have participated in the research work on the improvement of the standard of biochemical drugs organized by the National Pharmacopoeia Committee for many times. The company attaches importance to industry-university-research cooperation, and uses external forces to help the company's R & D and innovation capabilities to improve. It has cooperated with Chinese Academy of Sciences, Zhejiang University and other scientific research institutions, and has hired professors, doctors and researchers from well-known universities inside and outside the province as technical consultants.